Goodwin is a global law firm with more than 340 life sciences lawyers serving over 1,700 life sciences clients. Our healthcare and FDA regulatory teams advise pharmaceutical, biotechnology, and medical technology companies on drug pricing, market access, coverage and reimbursement, government price reporting, and compliance. Goodwin’s life sciences practice is ranked Band 1 nationwide by Chambers USA and was named a 2025 Life Sciences Practice Group of the Year by Law360. The firm is also an eight-time winner of Biotechnology Law Firm of the Year from U.S. News–Best Lawyers.